CTRI/2018/05/013754
Recruiting
未知
A Retrospective Safety Data Collection Registry of VivitraTM (Trastuzumab) - VivitraTM Registry
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- 1. Metastatic breast cancer2. Metastatic Gastric Cancer3. Early Breast Cancer
- Sponsor
- Cadila Healthcare Ltd
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient should have completed the 4 cycle of VivitraTM treatment on the approved indications
Exclusion Criteria
- •Any reason which may prevent the doctor to enroll the patient in the registry.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsMultiple Sclerosis patients who have participated in cladribine tablets clinical trialsMedDRA version: 20.1 Level: PT Classification code 10028245 Term: Multiple sclerosis System Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2009-017978-21-DEMerck Serono S.A. - Geneva1,148
Active, not recruiting
Phase 1
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsMultiple Sclerosis patients who have participated in cladribine tablets clinical trialsMedDRA version: 14.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 14.1Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2009-017978-21-ITMERCK SERONO SA1,148
Active, not recruiting
Phase 1
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsEUCTR2009-017978-21-EEMerck Serono S.A. - Geneva2,175
Active, not recruiting
Phase 1
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsEUCTR2009-017978-21-BEMerck Serono S.A. - Geneva1,148
Active, not recruiting
Phase 1
ong-term safety registry of Multiple Sclerosis patients who have participated in cladribine clinical trialsEUCTR2009-017978-21-LVMerck Serono S.A. - Geneva2,175